Your browser doesn't support javascript.
loading
Fulminant type 1 diabetes mellitus triggered by coronavirus disease 2019 vaccination in an advanced melanoma patient given adjuvant nivolumab therapy.
Ohuchi, Kentaro; Amagai, Ryo; Tamabuchi, Erika; Kambayashi, Yumi; Fujimura, Taku.
Affiliation
  • Ohuchi K; Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Amagai R; Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Tamabuchi E; Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Kambayashi Y; Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Fujimura T; Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
J Dermatol ; 49(5): e167-e168, 2022 05.
Article in En | MEDLINE | ID: mdl-35014070
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / Endocrine System Diseases / COVID-19 / Melanoma Limits: Humans Language: En Journal: J Dermatol Year: 2022 Document type: Article Affiliation country: Japón Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / Endocrine System Diseases / COVID-19 / Melanoma Limits: Humans Language: En Journal: J Dermatol Year: 2022 Document type: Article Affiliation country: Japón Country of publication: Reino Unido